Orthofix Medical Inc.
OFIX
$14.51
$0.010.07%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 203.12M | 193.65M | 215.66M | 196.61M | 198.62M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 203.12M | 193.65M | 215.66M | 196.61M | 198.62M |
Cost of Revenue | 63.59M | 72.03M | 63.77M | 61.55M | 63.87M |
Gross Profit | 139.53M | 121.62M | 151.89M | 135.05M | 134.75M |
SG&A Expenses | 136.49M | 132.98M | 136.48M | 130.14M | 134.22M |
Depreciation & Amortization | 3.87M | 3.04M | 4.34M | 4.55M | 4.32M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 219.89M | 227.81M | 223.40M | 213.54M | 220.46M |
Operating Income | -16.77M | -34.17M | -7.74M | -16.93M | -21.84M |
Income Before Tax | -14.22M | -52.13M | -29.71M | -26.64M | -32.36M |
Income Tax Expenses | -142.00K | 961.00K | -564.00K | 751.00K | 1.08M |
Earnings from Continuing Operations | -14.08M | -53.09M | -29.15M | -27.39M | -33.44M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -14.08M | -53.09M | -29.15M | -27.39M | -33.44M |
EBIT | -16.77M | -34.17M | -7.74M | -16.93M | -21.84M |
EBITDA | 1.23M | 1.52M | 19.55M | -141.00K | -6.30M |
EPS Basic | -0.36 | -1.35 | -0.75 | -0.71 | -0.88 |
Normalized Basic EPS | -0.24 | -0.60 | -0.41 | -0.40 | -0.48 |
EPS Diluted | -0.36 | -1.35 | -0.75 | -0.71 | -0.88 |
Normalized Diluted EPS | -0.24 | -0.60 | -0.41 | -0.40 | -0.48 |
Average Basic Shares Outstanding | 39.50M | 39.19M | 38.70M | 38.49M | 38.02M |
Average Diluted Shares Outstanding | 39.50M | 39.19M | 38.70M | 38.49M | 38.02M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |